Tumors of the Endocrine System

[1]  J. Isola,et al.  Chromogenic in situ hybridization-detected hotspot MYCN amplification associates with Ki-67 expression and inversely with nestin expression in neuroblastomas , 2005, Modern Pathology.

[2]  Hiroyuki Shimada,et al.  Chromosome 1p and 11q deletions and outcome in neuroblastoma. , 2005, The New England journal of medicine.

[3]  S. Suster,et al.  Primary parathyroid tumors of the mediastinum: a clinicopathologic and immunohistochemical study of 17 cases. , 2005, American journal of clinical pathology.

[4]  E. Baudin,et al.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. , 2005, The Journal of clinical endocrinology and metabolism.

[5]  H. Shimada,et al.  Neuroblastoma and Related Tumors , 2005 .

[6]  Jonathan R. Clark,et al.  Prognostic Variables and Calcitonin in Medullary Thyroid Cancer , 2005, The Laryngoscope.

[7]  Steven K. Libutti,et al.  Malignant insulinoma , 2005, Cancer.

[8]  Z. Baloch,et al.  Pathologic diagnosis of papillary thyroid carcinoma: today and tomorrow , 2005, Expert review of molecular diagnostics.

[9]  C. Harmer,et al.  Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome , 2005, Clinical endocrinology.

[10]  H. Holzhausen,et al.  The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma , 2005, Cancer.

[11]  S. Nordling,et al.  Prognostic Factors in Papillary Thyroid Cancer: An Evaluation of 601 Consecutive Patients , 2005, Tumor Biology.

[12]  K. Kovacs,et al.  Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors. , 2005, Clinical neuropathology.

[13]  J. Sosa,et al.  Current advances in the diagnosis and treatment of pancreatic endocrine tumors , 2005, Current opinion in oncology.

[14]  C. Lamas,et al.  Malignant prolactinoma with multiple bone and pulmonary metastases. Case report. , 2004, Journal of neurosurgery.

[15]  Herb Chen,et al.  Pancreatic endocrine tumors. , 2004, The Journal of surgical research.

[16]  D. Stram,et al.  Revision of the International Neuroblastoma Pathology Classification , 2003, Cancer.

[17]  L. Thompson.  Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases , 2002, The American journal of surgical pathology.

[18]  L. Akslen,et al.  Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma , 2000, Cancer.

[19]  M. Sobrinho-Simões.  Hail to the histologic grading of papillary thyroid carcinoma? , 2000, Cancer.

[20]  K K Matthay,et al.  The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.

[21]  G. Hejblum,et al.  Medullary thyroid carcinoma: search for histological predictors of survival (109 proband cases analysis). , 1998, Human pathology.

[22]  A. Foulis.  Book Review: AFIP Atlas of Tumot Patholgoy (3rd series, Fascicle 20). Tumours of the Pancreas. Enrico Solcia, Carlo Capella and Gunter Kloppel, Armed Forces Institute of Pathology, Washington, DC , 1998 .

[23]  S. Cohn,et al.  Advances in the diagnosis and treatment of neuroblastoma , 1998, Current opinion in oncology.

[24]  H. B. Marsden,et al.  Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. , 1984, Journal of the National Cancer Institute.

[25]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .

[26]  E. Baudin,et al.  Medullary Thyroid Carcinoma , 2016 .

[27]  B. Scheithauer,et al.  Prognostic indicators in pituitary tumors , 2005, Endocrine pathology.

[28]  H. Yamashita,et al.  Significance of an insular component in follicular thyroid carcinoma with distant metastasis at initial presentation , 2005, Endocrine pathology.

[29]  K. Kameyama,et al.  Proposal for the histological classification of parathyroid carcinoma , 2005, Endocrine pathology.

[30]  M. Papotti,et al.  Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid , 2004, Endocrine pathology.

[31]  P. Devos,et al.  A Clinicopathologic and Immunohistochemical Study of 49 Adrenocortical Tumors , 2002 .

[32]  B. Wenig,et al.  Atlas of endocrine pathology , 1997 .